{"id":54630,"date":"2023-03-08T14:06:24","date_gmt":"2023-03-08T13:06:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/"},"modified":"2023-03-08T14:06:24","modified_gmt":"2023-03-08T13:06:24","slug":"caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/","title":{"rendered":"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference"},"content":{"rendered":"
\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics<\/a> today announced that the Company will be participating in the 33rd<\/sup> Annual Oppenheimer Healthcare Conference on March 13, 2023.\n<\/p>\n

<\/a><\/p>\n

\nCaraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 programs from 4:40pm-5:10pm ET. In addition, the Company will be participating in 1-on-1 investor meetings during the conference.\n<\/p>\n

\n\u201cCaraway is making great progress on its preclinical TRPML1 programs for the treatment of Parkinson\u2019s and other rare diseases, and I look forward to discussing our work at this event and connecting with investors,\u201d said Williams.\n<\/p>\n

\nAbout Caraway Therapeutics<\/b>\n<\/p>\n

\nCaraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and rare diseases. The company is a leader in the cutting-edge science of activating cellular recycling processes to clear toxic materials and defective cellular components by modulating lysosomal function. Caraway is utilizing its unique product engine to develop proprietary insights into lysosomal function and small molecule ion channel modulation and advance a robust pipeline of precision therapeutic candidates with disease-modifying potential for patients. The company is backed by top-tier investors, including SV Health Investors, AbbVie Ventures, MRLV Fund, Amgen Ventures, Dementia Discovery Fund, Alexandria Venture Investments and Eisai Innovation.\n<\/p>\n

\nCaraway is based in Cambridge, MA. For more information, please visit www.carawaytx.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
MacDougall
\n
Carolyn Noyes
\n
(781) 235-3060
\n
cnoyes@macdougall.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the 33rd Annual Oppenheimer Healthcare Conference on March 13, 2023. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 programs from 4:40pm-5:10pm ET. In addition, the Company will be participating in 1-on-1 investor meetings during the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54630","6":"format-standard","7":"category-industry"},"yoast_head":"\nCaraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the 33rd Annual Oppenheimer Healthcare Conference on March 13, 2023. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 programs from 4:40pm-5:10pm ET. In addition, the Company will be participating in 1-on-1 investor meetings during the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-08T13:06:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230308005083\/en\/837856\/21\/CarawayTx_rgb_large.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference\",\"datePublished\":\"2023-03-08T13:06:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/\"},\"wordCount\":239,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005083\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/\",\"name\":\"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005083\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"datePublished\":\"2023-03-08T13:06:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005083\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005083\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference - Pharma Trend","og_description":"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the 33rd Annual Oppenheimer Healthcare Conference on March 13, 2023. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 programs from 4:40pm-5:10pm ET. In addition, the Company will be participating in 1-on-1 investor meetings during the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-08T13:06:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230308005083\/en\/837856\/21\/CarawayTx_rgb_large.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference","datePublished":"2023-03-08T13:06:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/"},"wordCount":239,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230308005083\/en\/837856\/21\/CarawayTx_rgb_large.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/","name":"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230308005083\/en\/837856\/21\/CarawayTx_rgb_large.jpg","datePublished":"2023-03-08T13:06:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230308005083\/en\/837856\/21\/CarawayTx_rgb_large.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230308005083\/en\/837856\/21\/CarawayTx_rgb_large.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Caraway Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54630"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54630\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}